LMAT
Lemaitre Vascular Inc

508
Mkt Cap
$2.02B
Volume
196,135.00
52W High
$105.55
52W Low
$71.42
PE Ratio
36.15
LMAT Fundamentals
Price
$84.00
Prev Close
$83.36
Open
$83.38
50D MA
$86.62
Beta
0.77
Avg. Volume
195,514.00
EPS (Annual)
$1.93
P/B
5.03
Rev/Employee
$331,118.98
Loading...
Loading...
News
all
press releases
First Trust Advisors LP Increases Stock Position in LeMaitre Vascular, Inc. $LMAT
First Trust Advisors LP grew its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 52.7% during the second quarter, according to the company in its most recent filing with...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. cut its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 13.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·5d ago
News Placeholder
LeMaitre Vascular (NASDAQ:LMAT) Cut to Hold at Wall Street Zen
Wall Street Zen lowered LeMaitre Vascular from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·7d ago
News Placeholder
Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve
LTH, CAH, LMAT and FLS emerge as high-coverage-ratio standouts for investors seeking sturdier balance-sheet safety into 2026.
Zacks·11d ago
News Placeholder
4 Stocks With High Coverage Ratios Offer Safer Bets Going Into 2026
High coverage ratios and earnings growth make CAH, LTH, LMAT and FLS safer investment bets heading into 2026.
Zacks·12d ago
News Placeholder
Here is Why Growth Investors Should Buy LeMaitre (LMAT) Now
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·16d ago
News Placeholder
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight brokerages that are presently covering the firm...
MarketBeat·19d ago
News Placeholder
LeMaitre Vascular, Inc. $LMAT Shares Sold by ProShare Advisors LLC
ProShare Advisors LLC cut its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 13.9% in the second quarter, according to its most recent disclosure with the SEC. The firm...
MarketBeat·28d ago
News Placeholder
New Strong Buy Stocks for November 14th
NPSNY, SUZ, EVCM, LMAT and TER have been added to the Zacks Rank #1 (Strong Buy) List on Nov.14, 2025
Zacks·29d ago
News Placeholder
3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT)
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks·1mo ago

Latest LMAT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.